Angiogenesis-modifying composition, useful for treatment or diagnosis of e.g. retinopathy, comprises inhibitor of expression of the insulin receptor substrate-1 gene

摘要

Angiogenesis-modifying composition (A) containing at least one of a nucleic acid (I) from the gene encoding IRS-1 (insulin receptor substrate-1), or its complement or fragments, or a molecule (II) that inhibits expression of the nucleic acid, is new.